Source: Intro to Biology, Penn State
Tags: dementia, Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, FTD, amyloid plaques, tau tangles, neurodegenerative disease, cognitive decline
Difficulty: Introductory | Prerequisites: None, though a basic understanding of cell biology (neurons, proteins) is helpful.
Dementia is not a single disease. It is an umbrella term for a group of neurodegenerative conditions that erode memory, reasoning and the ability to manage everyday life. This topic sits at the intersection of neuroscience, pathology and clinical medicine, and it recurs across ageing, pharmacology and public-health modules. If you can name the main types, explain what drives each one at a cellular level, and distinguish modifiable from non-modifiable risk factors, you have the foundation for everything that follows in diagnosis and management.
Dementia is a cluster of brain disorders that progressively destroy memory, thinking and independence. Alzheimer's disease accounts for the majority of cases, but vascular, Lewy body, frontotemporal and mixed forms each have distinct pathology and symptom profiles. Risk rises sharply after 65, though genetics, lifestyle and cardiovascular health all play a part.
Dementia
A broad clinical term for a range of neurological conditions characterised by cognitive decline severe enough to interfere with daily life, affecting memory, thinking, language, judgement and behaviour. In simple terms, it is not a single disease but a category, the way "infection" covers everything from a cold to sepsis.
Alzheimer's disease
The most common form of dementia, marked by progressive memory loss, disorientation and confusion, caused by the accumulation of amyloid plaques and tau tangles in the brain. Think of it as the "default" type: when someone says dementia without qualifying, they usually mean Alzheimer's.
Amyloid plaques
Abnormal clusters of beta-amyloid protein fragments that build up between neurons and disrupt cell communication. In simple terms, sticky protein clumps that gum up the spaces between brain cells.
Tau tangles (neurofibrillary tangles)
Twisted fibres of tau protein that form inside neurons, blocking the transport of nutrients and other essential materials. Think of it as the internal scaffolding of a neuron collapsing in on itself.
Vascular dementia
Dementia caused by reduced blood flow to the brain, typically following strokes or other cerebrovascular events. In simple terms, the brain is starved of oxygen because its blood supply is compromised.
Lewy bodies
Abnormal deposits of alpha-synuclein protein that develop inside nerve cells, associated with Lewy body dementia and Parkinson's disease. Think of them as rogue protein lumps that interfere with the brain's chemical signalling.
Frontotemporal dementia (FTD)
A group of disorders caused by progressive nerve-cell loss in the frontal and temporal lobes, leading to changes in personality, behaviour and language rather than early memory loss. In simple terms, the front of the brain deteriorates first, so personality and speech go before memory does.
Mixed dementia
A condition in which two or more types of dementia occur simultaneously, most commonly Alzheimer's disease and vascular dementia. Think of it as a combination platter: the patient has overlapping pathologies, which complicates both diagnosis and treatment.
Cholinesterase inhibitors
A class of drugs (e.g. donepezil, rivastigmine) that prevent the breakdown of acetylcholine, a neurotransmitter involved in memory and learning. In simple terms, these medications keep more of the brain's "memory chemical" available for use.
Memantine
A medication that regulates glutamate activity, used in moderate to severe Alzheimer's disease to slow symptom progression. Think of it as a chemical brake that stops overexcited brain cells from damaging themselves.
Alzheimer's disease
Accounts for 60 to 80 per cent of all dementia cases
Characterised by progressive memory loss, spatial disorientation and confusion
Pathology centres on two hallmark features:
Amyloid plaques: beta-amyloid protein fragments accumulate between neurons
Tau tangles: twisted tau protein fibres form inside neurons, disrupting intracellular transport
Onset is usually gradual, memory problems appearing first, with language and executive function declining later
Vascular dementia
Second most common type, caused by impaired blood flow to the brain
Often follows a stroke or series of mini-strokes (transient ischaemic attacks)
Cognitive decline may appear suddenly after a vascular event, or progress in a stepwise pattern
Symptoms tend to affect judgement, planning and organising more prominently than early memory loss
Key distinction from Alzheimer's: the deficit pattern often reflects which brain region lost blood supply
Lewy body dementia (LBD)
Caused by abnormal alpha-synuclein protein deposits (Lewy bodies) inside nerve cells
Distinctive features include visual hallucinations, fluctuating alertness and attention, and motor symptoms resembling Parkinson's disease (rigidity, slow movement, tremor)
Cognitive abilities can vary markedly from hour to hour or day to day
Overlaps significantly with Parkinson's disease dementia; the timing of motor versus cognitive symptoms is the clinical dividing line
Frontotemporal dementia (FTD)
Involves progressive nerve-cell loss in the frontal and temporal lobes
Tends to present earlier than other dementias, often between ages 45 and 65
Two broad clinical presentations:
Behavioural variant: personality change, social disinhibition, apathy, impulsivity
Language variant (primary progressive aphasia): progressive difficulty with speech production, word finding or comprehension
Memory may remain relatively intact in the early stages, which can delay diagnosis
Mixed dementia
Coexistence of two or more dementia pathologies, most commonly Alzheimer's disease and vascular dementia
Increasingly recognised at autopsy; many patients initially diagnosed with one type turn out to have overlapping pathology
Clinical picture can borrow symptoms from each contributing type, making pure classification difficult
Non-modifiable risk factors
Age: risk increases sharply after 65, roughly doubling every five years thereafter
Genetics: specific gene variants raise susceptibility, particularly in early-onset forms; the APOE-e4 allele is the strongest known genetic risk factor for late-onset Alzheimer's
Family history: having a first-degree relative with dementia increases risk, though it does not guarantee onset
Modifiable risk factors
Cardiovascular health: hypertension, diabetes, high cholesterol and obesity are all associated with increased risk, especially for vascular dementia
Lifestyle: smoking, excessive alcohol consumption, physical inactivity and poor diet each contribute independently
Head trauma: a history of significant head injuries (particularly repeated concussions) elevates risk later in life
Social and cognitive engagement: lower levels of education, social isolation and cognitive inactivity are linked to higher dementia risk, though causation is still debated
Real-world application
The distinction between modifiable and non-modifiable factors is clinically important because it underpins public-health messaging. Campaigns encouraging cardiovascular fitness, smoking cessation and cognitive engagement in mid-life are grounded in the evidence that these factors collectively account for a meaningful share of dementia risk.
Students often think dementia and Alzheimer's disease are the same thing. They are not. Alzheimer's is one type of dementia, the most common, but vascular, Lewy body, frontotemporal and mixed forms are distinct conditions with different pathologies.
Students often assume that memory loss is the earliest symptom of every type of dementia. In frontotemporal dementia, personality and behavioural changes typically appear first, with memory remaining relatively intact early on.
Students sometimes believe dementia is a normal part of ageing. It is not. While age is the strongest risk factor, dementia results from specific pathological changes in the brain and is not an inevitable consequence of growing older.
Students frequently confuse vascular dementia with Alzheimer's by assuming both follow the same gradual decline. Vascular dementia often progresses in a stepwise pattern, with sudden drops following vascular events, rather than a smooth downward curve.
⚠️ Be able to distinguish the five types of dementia by their defining pathology and primary symptom profile. A table-format question comparing Alzheimer's, vascular, Lewy body, FTD and mixed dementia is a common exam format.
⚠️ Know the difference between amyloid plaques (extracellular, between neurons) and tau tangles (intracellular, inside neurons). Mixing up their location is a frequent error.
⚠️ Expect a question on modifiable versus non-modifiable risk factors. Be ready to list at least three of each and explain why the distinction matters for public health.
⚠️ Lewy body dementia shares motor symptoms with Parkinson's disease. The clinical distinction rests on timing: if cognitive symptoms appear first (or within a year of motor symptoms), it is classified as LBD; if motor symptoms precede cognitive decline by more than a year, it is Parkinson's disease dementia.
True or false: Dementia is a specific disease rather than an umbrella term.
False. Dementia is a broad term covering multiple neurodegenerative conditions.
Fill in the blank: Alzheimer's disease is associated with the buildup of ______ between neurons and ______ inside neurons.
Amyloid plaques; tau tangles.
True or false: Vascular dementia typically follows a smooth, gradual decline.
False. It often progresses in a stepwise pattern following vascular events.
Fill in the blank: The type of dementia most likely to present with early personality changes rather than memory loss is ______.
Frontotemporal dementia (FTD).
True or false: Age is a modifiable risk factor for dementia.
False. Age is non-modifiable; cardiovascular health, diet and exercise are modifiable.
Q: Name the five main types of dementia covered in this lecture and give one distinguishing feature of each.
A: Alzheimer's disease (amyloid plaques and tau tangles), vascular dementia (caused by reduced cerebral blood flow, often post-stroke), Lewy body dementia (alpha-synuclein deposits, visual hallucinations), frontotemporal dementia (frontal/temporal lobe atrophy, early personality and language changes), and mixed dementia (two or more coexisting pathologies).
Q: Explain the difference between amyloid plaques and tau tangles in Alzheimer's disease.
A: Amyloid plaques are extracellular clusters of beta-amyloid protein fragments that accumulate between neurons and disrupt cell-to-cell communication. Tau tangles are intracellular twisted fibres of tau protein that form inside neurons and block the transport of nutrients and other essential materials.
Q: A patient presents with visual hallucinations, fluctuating alertness and a mild resting tremor. Which type of dementia is most consistent with this presentation?
A: Lewy body dementia. The combination of visual hallucinations, fluctuating cognition and parkinsonian motor symptoms is characteristic of LBD.
Q: List three modifiable and two non-modifiable risk factors for dementia.
A: Modifiable: hypertension (or cardiovascular disease generally), smoking, physical inactivity. Non-modifiable: age, genetic predisposition (e.g. APOE-e4 allele).
Q: Why might a patient with frontotemporal dementia receive a delayed diagnosis compared to a patient with Alzheimer's disease?
A: Because FTD typically presents with personality, behavioural or language changes rather than the memory loss that most people associate with dementia. The absence of early memory problems can lead clinicians and families to attribute symptoms to psychiatric conditions or stress rather than a neurodegenerative process.
This material connects directly to neuroscience modules covering neuronal structure and synaptic transmission, since understanding how plaques and tangles disrupt signalling is the mechanistic foundation. It also feeds into pharmacology (cholinesterase inhibitors and memantine act on the same neurotransmitter systems covered in synaptic physiology) and public health (epidemiology of ageing populations, modifiable risk-factor interventions).
dementia, Alzheimer's disease, AD, vascular dementia, multi-infarct dementia, Lewy body dementia, LBD, dementia with Lewy bodies, DLB, frontotemporal dementia, FTD, Pick's disease, mixed dementia, amyloid plaques, beta-amyloid, tau tangles, neurofibrillary tangles, alpha-synuclein, Lewy bodies, neurodegenerative disease, cognitive decline, memory loss, cholinesterase inhibitors, donepezil, rivastigmine, memantine, APOE-e4, risk factors for dementia, modifiable risk factors, cerebrovascular disease, brain ageing, dementia diagnosis, dementia types comparison